HUP0301447A2 - Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények - Google Patents

Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények

Info

Publication number
HUP0301447A2
HUP0301447A2 HU0301447A HUP0301447A HUP0301447A2 HU P0301447 A2 HUP0301447 A2 HU P0301447A2 HU 0301447 A HU0301447 A HU 0301447A HU P0301447 A HUP0301447 A HU P0301447A HU P0301447 A2 HUP0301447 A2 HU P0301447A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
compositions containing
combined pharmaceutical
containing tiotropium
salts
Prior art date
Application number
HU0301447A
Other languages
English (en)
Inventor
Juergen Nagel
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of HUP0301447A2 publication Critical patent/HUP0301447A2/hu
Publication of HUP0301447A3 publication Critical patent/HUP0301447A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

A találmány tárgyát a tiotrópiumsók és a salmeterolsók kombinációjánalapuló új gyógyszerkészítmények, eljárás az előállításukra, valaminta légúti megbetegedések terápiájában való alkalmazásuk képezi. Ó
HU0301447A 2000-11-13 2001-11-09 Combined pharmaceutical compositions containing tiotropium and salmeterol salts HUP0301447A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056104A DE10056104A1 (de) 2000-11-13 2000-11-13 Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
PCT/EP2001/012962 WO2002038154A1 (de) 2000-11-13 2001-11-09 Neue arzneimittelkompositionen auf der basis von tiotropiumsalzen und salzen des salmeterols

Publications (2)

Publication Number Publication Date
HUP0301447A2 true HUP0301447A2 (hu) 2003-10-28
HUP0301447A3 HUP0301447A3 (en) 2007-10-29

Family

ID=7663071

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301447A HUP0301447A3 (en) 2000-11-13 2001-11-09 Combined pharmaceutical compositions containing tiotropium and salmeterol salts

Country Status (32)

Country Link
EP (3) EP1808174A1 (hu)
JP (2) JP4282322B2 (hu)
KR (2) KR100886094B1 (hu)
CN (1) CN1678318A (hu)
AT (2) ATE291428T1 (hu)
AU (3) AU2791002A (hu)
BG (1) BG107781A (hu)
BR (1) BR0115226A (hu)
CA (1) CA2429012A1 (hu)
CY (1) CY1106774T1 (hu)
CZ (1) CZ20031444A3 (hu)
DE (3) DE10056104A1 (hu)
DK (2) DK1514546T3 (hu)
EA (1) EA007904B1 (hu)
EC (1) ECSP034571A (hu)
EE (1) EE200300228A (hu)
ES (2) ES2240549T3 (hu)
HR (1) HRP20030378A2 (hu)
HU (1) HUP0301447A3 (hu)
IL (2) IL155718A0 (hu)
MX (1) MXPA03004164A (hu)
NO (1) NO20032111L (hu)
NZ (1) NZ526400A (hu)
PL (1) PL205330B1 (hu)
PT (2) PT1514546E (hu)
RS (2) RS20090105A (hu)
SG (1) SG167657A1 (hu)
SI (2) SI1335728T1 (hu)
SK (2) SK286950B6 (hu)
UA (1) UA74853C2 (hu)
WO (1) WO2002038154A1 (hu)
ZA (1) ZA200302921B (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
JP2003514841A (ja) * 1999-11-23 2003-04-22 グラクソ グループ リミテッド サルメテロールの医薬製剤
JP2005504076A (ja) * 2001-09-14 2005-02-10 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 新規な吸入用医薬組成物
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
DE10256080A1 (de) * 2002-11-29 2004-06-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropiumhaltige Arzneimittelkombination für die Inhalation
US7250426B2 (en) 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
CN1726038A (zh) * 2002-12-16 2006-01-25 贝林格尔英格海姆法玛两合公司 含有噻托铵的hfc溶液剂
DE10351663A1 (de) * 2002-12-20 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverförmige Arzneimittel enthaltend ein Tiotropiumsalz und Salmeterolxinafoat
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
PE20050446A1 (es) 2003-11-03 2005-08-02 Boehringer Ingelheim Int Procedimiento para la preparacion de nuevas sales de tiotropio, nuevas sales de tiotropio como tales, asi como las formulaciones medicamentosas que las contienen
PE20050485A1 (es) * 2003-11-03 2005-10-05 Boehringer Ingelheim Int Nuevas sales de tiotropio, procedimiento para su preparacion, asi como formulaciones medicamentosas que las contienen
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
MXPA06013850A (es) * 2004-05-31 2007-03-02 Almirall Lab Combinaciones que comprenden agentes antimuscarinicos y corticosteroides.
PT1881980E (pt) 2005-05-02 2012-12-06 Boehringer Ingelheim Int Novas formas cristalinas de brometo de tiotrópio
CA2617897A1 (en) * 2005-08-06 2007-02-15 Boehringer Ingelheim International Gmbh Method for the treatment of dyspnea comprising combined administration of tiotropium salts and salts of salmeterol
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20120220557A1 (en) * 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
JP6335798B2 (ja) * 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
TW201835041A (zh) 2017-02-17 2018-10-01 印度商托仁特生技有限公司 具β-腎上腺素促效劑及抗蕈毒活性化合物
WO2019142214A1 (en) * 2018-01-19 2019-07-25 Cipla Limited Pharmaceutical composition comprising tiotropium for inhalation
CN111971034A (zh) * 2018-07-26 2020-11-20 四川海思科制药有限公司 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用
CN116173025A (zh) * 2018-07-26 2023-05-30 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
US11642372B2 (en) 2020-05-01 2023-05-09 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US11826382B2 (en) 2020-05-01 2023-11-28 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
WO2022119661A1 (en) * 2020-12-04 2022-06-09 Tygrus, LLC THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338753C (en) * 1998-07-24 2006-11-21 Jago Research Ag Medicinal aerosol formulations
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
DE19847970A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähige Wirkstoff-Formulierung
DE19847971A1 (de) * 1998-10-17 1999-09-02 Schiering Verfahren und Einrichtung zur Verhinderung von Filterbränden (Staubfilter)
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
DE19961300A1 (de) * 1999-12-18 2001-06-21 Asta Medica Ag Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator

Also Published As

Publication number Publication date
ES2287629T3 (es) 2007-12-16
ES2240549T3 (es) 2005-10-16
SI1514546T1 (sl) 2007-10-31
DE50105729D1 (de) 2005-04-28
UA74853C2 (en) 2006-02-15
HUP0301447A3 (en) 2007-10-29
NO20032111L (no) 2003-07-08
WO2002038154A1 (de) 2002-05-16
EP1514546A1 (de) 2005-03-16
KR100940752B1 (ko) 2010-02-11
EP1335728A1 (de) 2003-08-20
AU2791002A (en) 2002-05-21
JP2004513146A (ja) 2004-04-30
BG107781A (bg) 2004-06-30
AU2007202303B2 (en) 2010-01-21
EA200300503A1 (ru) 2004-12-30
EP1514546B1 (de) 2007-05-23
KR20030065509A (ko) 2003-08-06
DE50112535D1 (de) 2007-07-05
ECSP034571A (es) 2003-06-25
PT1514546E (pt) 2007-06-15
PT1335728E (pt) 2005-05-31
CN1678318A (zh) 2005-10-05
JP4282322B2 (ja) 2009-06-17
JP4282594B2 (ja) 2009-06-24
JP2005068163A (ja) 2005-03-17
RS50286B (sr) 2009-09-08
AU2007202303A1 (en) 2007-06-14
PL365989A1 (en) 2005-01-24
BR0115226A (pt) 2003-10-07
PL205330B1 (pl) 2010-04-30
EA007904B1 (ru) 2007-02-27
EP1335728B1 (de) 2005-03-23
IL155718A0 (en) 2003-11-23
SG167657A1 (en) 2011-01-28
HRP20030378A2 (en) 2005-04-30
SK286950B6 (sk) 2009-08-06
KR100886094B1 (ko) 2009-02-27
SI1335728T1 (en) 2005-08-31
YU35503A (sh) 2006-05-25
NZ526400A (en) 2005-09-30
SK286939B6 (sk) 2009-07-06
ATE291428T1 (de) 2005-04-15
CZ20031444A3 (cs) 2003-08-13
ATE362761T1 (de) 2007-06-15
KR20080079701A (ko) 2008-09-01
RS20090105A (en) 2009-07-15
DE10056104A1 (de) 2002-05-23
NO20032111D0 (no) 2003-05-12
CA2429012A1 (en) 2002-05-16
IL155718A (en) 2010-06-30
AU2002227910B2 (en) 2007-03-01
MXPA03004164A (es) 2005-08-16
DK1335728T3 (da) 2005-04-18
DK1514546T3 (da) 2007-09-24
EE200300228A (et) 2003-10-15
CY1106774T1 (el) 2012-05-23
EP1808174A1 (de) 2007-07-18
ZA200302921B (en) 2004-04-19
SK7412003A3 (en) 2003-10-07

Similar Documents

Publication Publication Date Title
HUP0301447A2 (hu) Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények
HUP0400782A2 (hu) Antikolinergikumokon és PDE-IV inhibitorokon alapuló új gyógyszerkészítmények
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
UY27757A1 (es) Medicamento que contiene betamiméticos y un nuevo anticolinérgico.
HUP0302874A2 (hu) Eljárás risperidon előállítására
HK1068606A1 (en) Novel aminobenzoephenones
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
SE0102440D0 (sv) New compound
ATE271852T1 (de) Verbesserte inhalationspräparate
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
HUP0200145A2 (hu) Tianeptin alkalmazása neurodegeneratív betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
HUP0401782A2 (hu) Új, vízmentes kristályos gabapentin formák
HUP0402298A2 (hu) Dezoxipeganin alkalmazása klinikai depresszió kezelésére
ATE452639T1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen
MXPA03008406A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina.
MY141724A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
HUP0300876A2 (hu) Diklofenaksók alkalmazása égési sérülések helyi kezelésére használható gyógyszerkészítmény előállítására
HUP0301337A2 (hu) Terbinafint tartalmazó orális gyógyszerkészítmények és alkalmazásuk
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees